Temporary ovarian suppression with hormone analogue may preserve fertility during breast cancer chemotherapy

Bookmark and Share
Published: 7 Dec 2017
Views: 1562
Rating:
Save
Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium

Dr Lambertini speaks at a SABCS 2017 press session about a meta-analysis of individual patient data from five randomised clinical trials provided a high level of evidence that treatment with a gonadotropin-releasing hormone analog (GnRHa) could safely and effectively protect ovarian function, and potentially preserve fertility in premenopausal women receiving chemotherapy for early-stage breast cancer.

Read the news story for more.